Search tips
Search criteria 


Logo of brheartjLink to Publisher's site
Br Heart J. 1989 February; 61(2): 139–143.
PMCID: PMC1216630

Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.


Plasma concentrations of immunoreactive atrial natriuretic peptide (mean (SEM] were measured in 135 patients admitted to two coronary care units with myocardial infarction, ischaemic chest pain, or non-ischaemic chest pain. Concentrations were significantly higher in patients with acute myocardial infarction not treated with systemic thrombolysis (60.4 (14.3) pg/ml) than in patients with non-ischaemic chest pain (21.1 (4.3) pg/ml). Patients with ischaemic chest pain had intermediate values (39.3 (7.1) pg/ml). Patients with acute myocardial infarction treated with intravenous streptokinase had normal concentrations of plasma atrial natriuretic peptide (20.2 (3.6) pg/mg), which were significantly lower than those in patients with myocardial infarction not given streptokinase. These changes could not be explained by factors such as age, pre-existing hypertension, renal dysfunction, or cardiac failure, nor treatment other than streptokinase. Raised plasma concentrations of atrial natriuretic peptide in acute myocardial infarction may be a homoeostatic response acting to reduce atrial pressures by natriuresis, diuresis, and venodilatation. The lower concentrations of atrial natriuretic peptide in patients with acute myocardial infarction treated with streptokinase may reflect a short term beneficial haemodynamic effect of streptokinase.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (829K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest. 1985 Oct;76(4):1705–1709. [PMC free article] [PubMed]
  • Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet. 1985 Nov 30;2(8466):1208–1211. [PubMed]
  • Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man. Clin Sci (Lond) 1986 Aug;71(2):151–155. [PubMed]
  • Tikkanen I, Fyhrquist F, Metsärinne K, Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet. 1985 Jul 13;2(8446):66–69. [PubMed]
  • Burnett JC, Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. [PubMed]
  • Raine AE, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. [PubMed]
  • Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation. 1986 Jun;73(6):1155–1161. [PubMed]
  • Arendt RM, Gerbes AL, Ritter D, Stangl E, Bach P, Zähringer J. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertens Suppl. 1986 Jun;4(2):S131–S135. [PubMed]
  • Anderson JV, Woodruff PW, Bloom SR. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J. 1988 Feb;59(2):207–211. [PMC free article] [PubMed]
  • Richards AM, Nicholls MG, Ikram H, Webster MW, Yandle TG, Espiner EA. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. [PubMed]
  • Rascher W, Tulassay T, Lang RE. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet. 1985 Aug 10;2(8450):303–305. [PubMed]
  • Anderson JV, Raine AE, Proudler A, Bloom SR. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. J Endocrinol. 1986 Aug;110(2):193–196. [PubMed]
  • Ogawa K, Smith AI, Hodsman GP, Jackson B, Woodcock EA, Johnston CI. Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clin Exp Pharmacol Physiol. 1987 Feb;14(2):95–102. [PubMed]
  • Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab. 1986 Oct;63(4):819–822. [PubMed]
  • Killip T, 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967 Oct;20(4):457–464. [PubMed]
  • Larochelle P, Cusson JR, Gutkowska J, Schiffrin EL, Hamet P, Kuchel O, Genest J, Cantin M. Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J (Clin Res Ed) 1987 May 16;294(6582):1249–1252. [PMC free article] [PubMed]
  • Ohashi M, Fujio N, Nawata H, Kato K, Ibayashi H, Kangawa K, Matsuo H. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab. 1987 Jan;64(1):81–85. [PubMed]
  • Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985 Mar 21;314(6008):264–266. [PubMed]
  • Dietz JR. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol. 1984 Dec;247(6 Pt 2):R1093–R1096. [PubMed]
  • Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res. 1986 Sep;59(3):256–261. [PubMed]
  • Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI. Neurohumoral responses to chronic myocardial infarction in rats. Circulation. 1988 Aug;78(2):376–381. [PubMed]
  • Matsubara H, Nishikawa M, Umeda Y, Taniguchi T, Iwasaka T, Kurimoto T, Yamane Y, Inada M. The role of atrial pressure in secreting atrial natriuretic polypeptides. Am Heart J. 1987 Jun;113(6):1457–1463. [PubMed]
  • White HD, Norris RM, Brown MA, Takayama M, Maslowski A, Bass NM, Ormiston JA, Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987 Oct 1;317(14):850–855. [PubMed]
  • Köhler M, Hellstern P, Doenecke P, Schwerdt H, Ozbek C, Miyashita C, Winter R, von Blohn G, Bette L, Wenzel E. High-dose systemic streptokinase and acylated streptokinase-plasminogen complex (BRL 26921) in acute myocardial infarction: alterations of the fibrinolytic system and clearance of fibrinolytic activity. Haemostasis. 1987;17(1-2):32–39. [PubMed]
  • Anderson J, Struthers A, Christofides N, Bloom S. Atrial natriuretic peptide: an endogenous factor enhancing sodium excretion in man. Clin Sci (Lond) 1986 Apr;70(4):327–331. [PubMed]
  • Andersson RG, Saldeen K, Saldeen T. A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP. Thromb Res. 1983 May 1;30(3):213–218. [PubMed]
  • Gutkowska J, Racz K, Garcia R, Thibault G, Kuchel O, Genest J, Cantin M. The morphine effect on plasma ANF. Eur J Pharmacol. 1986 Nov 12;131(1):91–94. [PubMed]
  • Schiebinger RJ, Linden J. Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am J Physiol. 1986 Nov;251(5 Pt 2):H1095–H1099. [PubMed]
  • Anderson JV, Gibbs JS, Woodruff PW, Greco C, Rowland E, Bloom SR. The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens Suppl. 1986 Jun;4(2):S137–S141. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group